NCT03117972 2025-02-05
CLavSyn
Centre Hospitalier Universitaire de Besancon
Phase 2 Terminated
Clinical Trials
10 trialsNCT05081687 2023-10-11
BRAZIL-TNT
Hospital Israelita Albert Einstein
Phase 3 Unknown
NCT01328171 2023-06-15
VOLFI
AIO-Studien-gGmbH
Phase 2 Completed
NCT05316818 2022-04-07
Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma
Kasr El Aini Hospital
Phase 2 Completed
NCT03487939 2021-04-19
Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer
China Medical University, China
Phase 2 Unknown
NCT02063529 2020-03-31
FOCULM
Sun Yat-sen University
Phase 2 Completed
NCT03504618 2018-04-20
Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI
Hanoi Medical University
Completed
NCT02350530 2016-09-20
FORBES
Sun Yat-sen University
Phase 2 Unknown
NCT01219920 2015-03-11
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest
Phase 3 Completed
NCT02128425 2014-05-07
FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2 Unknown